{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:22:44Z","timestamp":1790202164317,"version":"4.1.0"},"reference-count":32,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T00:00:00Z","timestamp":1702598400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"Background<\/jats:title>Among patients with nosocomial bacterial pneumonia, those who decompensated to requiring mechanical ventilation (vHABP) faced the highest mortality followed by ventilator-associated pneumonia (VABP) and non-ventilated hospital-acquired pneumonia (nvHABP). The objectives of this study were to identify risk factors associated with the development and mortality of vHABP and to evaluate antibiotic management.<\/jats:p><\/jats:sec>Methods<\/jats:title>A multicenter retrospective cohort study of adult inpatients with nosocomial pneumonia during 2014\u20132019 was performed. Groups were stratified by vHABP, nvHABP, and VABP and compared on demographics, clinical characteristics, treatment, and outcomes. Multivariable models were generated via machine learning to identify risk factors for progression to vHABP as well as pneumonia-associated mortality for each cohort.<\/jats:p><\/jats:sec>Results<\/jats:title>457 patients (32% nvHABP, 37% vHABP, and 31% VABP) were evaluated. The vHABP and nvHABP groups were similar in age (median age 66.4 years) with 77% having multiple comorbidities but more vHABP patients had liver disease (18.2% vs. 7.7% p<\/jats:italic>\u2009=\u20090.005), alcohol use disorder (27% vs. 7.1%, p<\/jats:italic>\u2009&lt;\u20090.0001), and were hospitalized within the past 30\u2009 days (30.4% vs. 19.5%, p<\/jats:italic>\u2009=\u20090.02). An immediate need for ventilatory support occurred in 70% of vHABP patients on the day of diagnosis. Mortality was the highest in vHABP followed by VABP and nvHABP groups (44.6% vs. 36% vs. 14.3%, p<\/jats:italic>\u2009&lt;\u20090.0001). Nearly all (96%) vHABP patients had positive cultures, with Gram-negative pathogens accounting for 58.8% whereby 33.0% were resistant to extended-spectrum \u03b2-lactams (ESBLs), ceftriaxone (17.5%), fluoroquinolones (20.6%), and carbapenems (12.4%). Up to half of the vHABP patients with ESBL-Enterobacterales or P. aeruginosa<\/jats:italic> did not receive an effective empiric regimen; over 50% increase in mortality rate was observed among patients whom effective therapy was initiated past the day of pneumonia diagnosis. Risk factors associated with vHABP development were alcohol use disorder, APACHE II score, vasopressor therapy prior to infection, and culture positive for ESBL-Enterobacterales whereas history of hospitalization in the past 30 \u2009days, active malignancy, isolation of ceftriaxone-resistant pathogens or Pseudomonas aeruginosa<\/jats:italic>, and vasopressor therapy were risk factors for vHABP-associated mortality.<\/jats:p><\/jats:sec>Conclusion<\/jats:title>Patients with vHABP experienced an acute and severe decompensation upon diagnosis. The risk factors identified in this study could provide actionable data for clinicians to identify those at risk for vHABP at the onset of pneumonia and to target antimicrobial stewardship efforts to improve treatment success.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1268488","type":"journal-article","created":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T15:11:18Z","timestamp":1702998678000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":15,"title":["Machine learning to identify risk factors associated with the development of ventilated hospital-acquired pneumonia and mortality: implications for antibiotic therapy selection"],"prefix":"10.3389","volume":"10","author":[{"given":"Anthony","family":"Sophonsri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Ny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emi","family":"Minejima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Nieberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Wong-Beringer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,12,15]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.2147\/IDR.S177247","article-title":"Health care-associated infections \u2013 an overview","volume":"11","author":"Haque","year":"2018","journal-title":"Infect Drug Resist"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"e61","DOI":"10.1093\/cid\/ciw353","article-title":"Management of adults with hospital-acquired and ventilator-associated pneumonia: 2016 clinical practice guidelines by the Infectious Diseases Society of America and the American Thoracic Society","volume":"63","author":"Kalil","year":"2016","journal-title":"Clin Infect Dis"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1056\/NEJMoa1306801","article-title":"Multistate point-prevalence survey of health care-associated infections","volume":"370","author":"Magill","year":"2014","journal-title":"N Engl J Med"},{"key":"ref4","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1097\/CCM.0000000000005298","article-title":"Descriptive epidemiology and outcomes of nonventilated hospital-acquired, ventilated hospital-acquired, and ventilator-associated bacterial pneumonia in the United States, 2012-2019","volume":"50","author":"Zilberberg","year":"2022","journal-title":"Crit Care Med"},{"key":"ref5","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1186\/s13054-020-03091-2","article-title":"Update of the treatment of nosocomial pneumonia in the ICU","volume":"24","author":"Zaragoza","year":"2020","journal-title":"Crit Care"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"1536","DOI":"10.1093\/infdis\/jiy578","article-title":"Evidence-based study design for hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"219","author":"Talbot","year":"2019","journal-title":"J Infect Dis"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1016\/j.ccm.2018.08.004","article-title":"Is zero ventilator-associated pneumonia achievable? Practical approaches to ventilator-associated pneumonia prevention","volume":"39","author":"Vazquez Guillamet","year":"2018","journal-title":"Clin Chest Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1378\/chest.127.1.213","article-title":"Multicenter study of hospital-acquired pneumonia in non-ICU patients","volume":"127","author":"Sopena","year":"2005","journal-title":"Chest"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1056\/NEJMsa1300991","article-title":"National trends in patient safety for four common conditions, 2005-2011","volume":"370","author":"Wang","year":"2014","journal-title":"N Engl J Med"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"e0867","DOI":"10.1097\/CCE.0000000000000867","article-title":"Determinants of mortality for ventilated hospital-acquired pneumonia and ventilator-associated pneumonia","volume":"5","author":"Motowski","year":"2023","journal-title":"Crit Care Explor"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1023\/A:1010933404324","article-title":"Random forests","volume":"45","author":"Breiman","year":"2001","journal-title":"Mach Learn"},{"key":"ref12","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/s12890-022-02031-w","article-title":"Early prediction of ventilator-associated pneumonia in critical care patients: a machine learning model","volume":"22","author":"Liang","year":"2022","journal-title":"BMC Pulm Med"},{"key":"ref13","first-page":"467","article-title":"Deep learning from incomplete data: detecting imminent risk of hospital-acquired pneumonia in ICU patients","volume":"2019","author":"Goodwin","year":"2020","journal-title":"AMIA Annu Symp Proc"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"388","DOI":"10.1164\/rccm.200405-644ST","article-title":"Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia","volume":"171","year":"2005","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1016\/j.jbi.2008.08.010","article-title":"Research electronic data capture (REDCAP)\u2014a metadata-driven methodology and workflow process for providing translational research informatics support","volume":"42","author":"Harris","year":"2009","journal-title":"J Biomed Inform"},{"key":"ref16","doi-asserted-by":"publisher","first-page":"3305","DOI":"10.5194\/bg-13-3305-2016","article-title":"Modelling interannual variation in the spring and autumn land surface phenology of the European forest","volume":"13","author":"Rodriguez-Galiano","year":"2016","journal-title":"Biogeosciences"},{"key":"ref17","first-page":"18","article-title":"Classification and regression by random forest","volume":"2","author":"Liaw","year":"2002","journal-title":"R news 23"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1177\/096228029900800102","article-title":"Multiple imputation: a primer","volume":"8","author":"Schafer","year":"1999","journal-title":"Stat Methods Med Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.1890\/07-0539.1","article-title":"Random forests for classification in ecology","volume":"88","author":"Cutler","year":"2007","journal-title":"Ecology"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1186\/s12859-018-2264-5","article-title":"Random forest versus logistic regression: a large-scale benchmark experiment","volume":"19","author":"Couronn\u00e9","year":"2018","journal-title":"BMC Bioinformatics"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1021\/ci034160g","article-title":"Random forest: a classification and regression tool for compound classification and QSAR modeling","volume":"43","author":"Svetnik","year":"2003","journal-title":"J Chem Inf Comput Sci"},{"key":"ref22","doi-asserted-by":"publisher","first-page":"Article 1","DOI":"10.7275\/1wpr-m024","article-title":"Random forest as a predictive analytics alternative to regression in institutional research","volume":"23","author":"Lingjun","year":"2019","journal-title":"Pract Assess Res Eval"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.cgh.2011.02.031","article-title":"Immune dysfunction and infections in patients with cirrhosis","volume":"9","author":"Bonnel","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1186\/1471-230X-13-25","article-title":"High mortality of pneumonia in cirrhotic patients with ascites","volume":"13","author":"Hung","year":"2013","journal-title":"BMC Gastroenterol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1186\/s12931-018-0934-5","article-title":"Pneumonia in patients with cirrhosis: risk factors associated with mortality and predictive value of prognostic models","volume":"19","author":"Xu","year":"2018","journal-title":"Respir Res"},{"key":"ref26","doi-asserted-by":"publisher","first-page":"1789","DOI":"10.1017\/S0950268810000774","article-title":"Alcohol consumption as a risk factor for pneumonia: a systematic review and meta-analysis","volume":"138","author":"Samokhvalov","year":"2010","journal-title":"Epidemiol Infect"},{"key":"ref27","doi-asserted-by":"publisher","first-page":"1446","DOI":"10.1001\/archinte.1997.00440340078008","article-title":"The impact of alcohol-related diagnoses on pneumonia outcomes","volume":"157","author":"Saitz","year":"1997","journal-title":"Arch Intern Med"},{"key":"ref28","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1378\/chest.129.5.1219","article-title":"Impact of alcohol abuse in the etiology and severity of community-acquired pneumonia","volume":"129","author":"de Roux","year":"2006","journal-title":"Chest"},{"key":"ref29","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1177\/2049936117727497","article-title":"Risk factors and outcomes for multidrug-resistant gram-negative bacilli bacteremia","volume":"5","author":"Patolia","year":"2018","journal-title":"Ther Adv Infect Dis"},{"key":"ref30","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1186\/s12879-018-3524-8","article-title":"A systematic review of the association between delayed appropriate therapy and mortality among patients hospitalized with infections due to Klebsiella pneumoniae or Escherichia coli: how long is too long?","volume":"18","author":"Lodise","year":"2018","journal-title":"BMC Infect Dis"},{"key":"ref31","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/377200","article-title":"Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome","volume":"37","author":"Kang","year":"2003","journal-title":"Clin Infect Dis"},{"key":"ref32","doi-asserted-by":"publisher","first-page":"3510","DOI":"10.1128\/AAC.00338-07","article-title":"Predictors of 30-day mortality among patients with Pseudomonas aeruginosa bloodstream infections: impact of delayed appropriate antibiotic selection","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1268488\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T15:11:24Z","timestamp":1702998684000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1268488\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,12,15]]},"references-count":32,"alternative-id":["10.3389\/fmed.2023.1268488"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1268488","relation":{},"ISSN":["2296-858X"],"issn-type":[{"value":"2296-858X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,12,15]]},"article-number":"1268488"}}